This topic contains a solution. Click here to go to the answer

Author Question: If a researcher were to use deception as part of her experimental procedure, when would she explain ... (Read 145 times)

james0929

  • Hero Member
  • *****
  • Posts: 586
If a researcher were to use deception as part of her experimental procedure, when would she explain the purpose of this deception to her participants?
 
  a. during the debriefing
  b. before obtaining informed consent
  c. immediately preceding the experimental manipulation
  d. before collecting any dependent measures

Question 2

Which of the following is one of the ethical principles that psychologists must follow when using human participants? All participants must be
 
  a. informed that they can withdraw from the study at any time.
  b. informed of the true nature of the study upon arriving at the laboratory.
  c. contacted six months after the study to assure that no psychological harm resulted.
  d. compensated in some way for their participation in research.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

katkat_flores

  • Sr. Member
  • ****
  • Posts: 328
Answer to Question 1

Answer: A

Answer to Question 2

Answer: A





 

Did you know?

The calories found in one piece of cherry cheesecake could light a 60-watt light bulb for 1.5 hours.

Did you know?

The largest baby ever born weighed more than 23 pounds but died just 11 hours after his birth in 1879. The largest surviving baby was born in October 2009 in Sumatra, Indonesia, and weighed an astounding 19.2 pounds at birth.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

Did you know?

In inpatient settings, adverse drug events account for an estimated one in three of all hospital adverse events. They affect approximately 2 million hospital stays every year, and prolong hospital stays by between one and five days.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library